HC Surgical Specialists Limited (SGX:1B1)

Singapore flag Singapore · Delayed Price · Currency is SGD
0.345
-0.010 (-2.82%)
At close: Mar 4, 2026
21.05%
Market Cap 52.91M
Revenue (ttm) 19.14M
Net Income (ttm) 9.03M
Shares Out 153.38M
EPS (ttm) 0.06
PE Ratio 5.87
Forward PE n/a
Dividend 0.02 (5.86%)
Ex-Dividend Date Mar 2, 2026
Volume 12,900
Average Volume 24,015
Open 0.350
Previous Close 0.355
Day's Range 0.345 - 0.350
52-Week Range 0.270 - 0.385
Beta -0.11
RSI 35.77
Earnings Date Apr 9, 2026

About HC Surgical Specialists

HC Surgical Specialists Limited, an investment holding company, provides medical services primarily in Singapore. The company provides endoscopic procedures, including gastroscopies and colonoscopies; and general surgery services with a focus on colorectal procedures in a network of clinics. It also offers treatment services for other conditions, such as haemorrhoids, anal fissure, hernia, anal abscess, cholecystitis, anal fistula, appendicitis, colorectal cancer, lipomas, cysts, and gastric cancer, vein laser vascular, laparoscopy, and other g... [Read more]

Industry Offices and Clinics of Doctors of Medicine
Founded 2015
Employees 18
Stock Exchange Singapore Exchange - Catalist
Ticker Symbol 1B1
Full Company Profile

Financial Performance

In fiscal year 2025, HC Surgical Specialists's revenue was 19.30 million, an increase of 1.77% compared to the previous year's 18.97 million. Earnings were 8.44 million, an increase of 119.42%.

Financial Statements

News

There is no news available yet.